These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6197757)

  • 21. Arabinosylcytosine induces fetal hemoglobin in baboons by perturbing erythroid cell differentiation kinetics.
    Papayannopoulou T; Torrealba de Ron A; Veith R; Knitter G; Stamatoyannopoulos G
    Science; 1984 May; 224(4649):617-9. PubMed ID: 6200940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic manipulation of fetal hemoglobin synthesis.
    Dover GJ; Humphries RK; Young N; Ley T; Boyer S; Charache S; Nienhuis A
    Prog Clin Biol Res; 1985; 191():447-54. PubMed ID: 2413480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of fetal hemoglobin synthesis by cell cycle specific drugs.
    Nathan DG
    Prog Clin Biol Res; 1985; 191():475-500. PubMed ID: 2413483
    [No Abstract]   [Full Text] [Related]  

  • 24. Chemotherapy to increase fetal hemoglobin in patients with sickle cell anemia.
    Platt OS
    Am J Pediatr Hematol Oncol; 1985; 7(3):258-60. PubMed ID: 2416231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Augmentation of hemoglobin synthesis by S-phase specific drugs in the K562 cell line.
    Dean A; Wu YJ; Ley T; Fordis CM; Schechter AN
    Prog Clin Biol Res; 1985; 191():205-16. PubMed ID: 2413473
    [No Abstract]   [Full Text] [Related]  

  • 26. Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea.
    Veith R; Galanello R; Papayannopoulou T; Stamatoyannopoulos G
    N Engl J Med; 1985 Dec; 313(25):1571-5. PubMed ID: 2415821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA hypomethylation therapies and hemoglobin disorders. [An interview with Hassana Fathallah by H&O].
    Fathallah H
    Clin Adv Hematol Oncol; 2008 Nov; 6(11):806-8. PubMed ID: 19194363
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacologic induction of fetal hemoglobin: raising the therapeutic bar in sickle cell disease.
    Atweh GF; Schechter AN
    Curr Opin Hematol; 2001 Mar; 8(2):123-30. PubMed ID: 11224687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treating sickle cell anemia: A new era dawns.
    Steinberg MH
    Am J Hematol; 2020 Apr; 95(4):338-342. PubMed ID: 31925819
    [No Abstract]   [Full Text] [Related]  

  • 30. Levels of fetal hemoglobin necessary for treatment of sickle cell disease.
    Noguchi CT; Rodgers GP; Serjeant G; Schechter AN
    N Engl J Med; 1988 Jan; 318(2):96-9. PubMed ID: 2447498
    [No Abstract]   [Full Text] [Related]  

  • 31. 5-Azacytidine increases fetal hemoglobin production in a patient with sickle cell disease.
    Dover GJ; Charache SH; Boyer SH; Talbot CC; Smith KD
    Prog Clin Biol Res; 1983; 134():475-88. PubMed ID: 6198661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-Azacytidine acts directly on both erythroid precursors and progenitors to increase production of fetal hemoglobin.
    Humphries RK; Dover G; Young NS; Moore JG; Charache S; Ley T; Nienhuis AW
    J Clin Invest; 1985 Feb; 75(2):547-57. PubMed ID: 2579100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of sickle cell anemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the gamma-delta-beta-globin gene complex.
    Charache S; Dover G; Smith K; Talbot CC; Moyer M; Boyer S
    Proc Natl Acad Sci U S A; 1983 Aug; 80(15):4842-6. PubMed ID: 6192443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Augmentation of fetal-hemoglobin production in anemic monkeys by hydroxyurea.
    Letvin NL; Linch DC; Beardsley GP; McIntyre KW; Nathan DG
    N Engl J Med; 1984 Apr; 310(14):869-73. PubMed ID: 6199670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy and hemoglobin F synthesis in sickle cell disease.
    Dover GJ; Charache S
    Ann N Y Acad Sci; 1989; 565():222-7. PubMed ID: 2476061
    [No Abstract]   [Full Text] [Related]  

  • 36. Increasing fetal hemoglobin production in sickle cell disease: results of clinical trials.
    Dover GJ; Charache S
    Prog Clin Biol Res; 1987; 251():455-66. PubMed ID: 2448813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulation of fetal hemoglobin production by hydroxyurea in sickle cell anemia.
    Dover GJ; Charache S
    Prog Clin Biol Res; 1989; 316B():295-306. PubMed ID: 2482499
    [No Abstract]   [Full Text] [Related]  

  • 38. On the mechanism of Hb F elevations in the baboon by erythropoietic stress and pharmacologic manipulation.
    Lavelle D; DeSimone J; Heller P; Zwiers D; Hall L
    Blood; 1986 Apr; 67(4):1083-9. PubMed ID: 2420395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene switching -- a new therapeutic epoch: discussion paper.
    Nalbandian RM; Cypress GC
    J R Soc Med; 1984 Mar; 77(3):217-20. PubMed ID: 6199499
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality.
    Pearson HA
    Adv Pediatr; 1996; 43():309-34. PubMed ID: 8794181
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.